Shavano Park, Texas Clinical Trials

A listing of Shavano Park, Texas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 49 clinical trials
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

immunomodulator
cancer
durvalumab
maintenance therapy
carcinoma
Research Site
 (5.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +94 other locations
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168

Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMS Secondary Objective: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonsnce imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety and tolerability of SAR442168 …

chronic progressive multiple sclerosis
contraceptive use
multiple sclerosis
Investigational Site Number 8400036
 (6.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168

Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMS Secondary Objective: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonance imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety and tolerability of SAR442168 …

chronic progressive multiple sclerosis
contraceptive use
secondary progressive multiple sclerosis
multiple sclerosis
Investigational Site Number 8400036
 (6.3 away) Contact site
  • 0 views
  • 12 Nov, 2020
  • +15 other locations
A Study of SY 5609 a Selective CDK7 Inhibitor in Advanced Solid Tumors

This is a dose escalation study and will be the first to administer SY-5609 alone to humans with select advanced solid tumors and in combination with Fulvestrant to patients with HR positive, HER2-negative breast cancer.

her2/neu-negative breast cancer
gonadotropin
solid tumor
cancer
alopecia
South Texas Accelerated Research Theraputics (START), LLC
 (5.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

pleural effusion
refractory non-hodgkin lymphoma
MRI
growth factor
platelet transfusion
Methodist Children's Hospital of South Texas
 (5.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +82 other locations
Multicenter Clinical Trial of a Phakic Implantable Collamer Lens (ICL)

This objective of this study is to evaluate the safety, and to collect supportive data on effectiveness of the EVO/EVO+ Visian Implantable Collamer Lens (ICL) in study participants who have a diagnosis of myopia or myopia with astigmatism. Primary study analysis will be evaluated when 300 primary eyes complete 6 …

astigmatism
severe myopia
myopia
Parkhurst NuVision
 (5.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +13 other locations
A Phase 1 Multi-Center Safety Dose Escalation Pharmacokinetics of INV-1120 in Adult Patients Advanced Solid Tumors

Phase 1, first-in-human, open-label dose-escalation study to determine the MTD and RP2D, and to assess the DLT of INV-1120 (also referred to as investigational product or IP). The safety, tolerability, and PK of INV-1120 will be assessed in adult patients with advanced solid tumors.

serum pregnancy test
solid neoplasm
ct scan
bone marrow procedure
measurable disease
START
 (5.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b

Phase 1b, a study in high grade serous ovarian cancer and nonsmall cell lung cancer to evaluate the safety and clinical activity of the antibody-drug conjugate (ADC) XMT-1592.

non-small cell lung cancer
hormonal contraception
measurable disease
cancer
lung cancer
NEXT Oncology
 (5.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
NCI COVID-19 in Cancer Patients NCCAPS Study

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects …

nucleic acid
BRAF
targeted radionuclide therapy
oropharyngeal
malignant solid neoplasm
University of Texas Health Science Center at San Antonio
 (5.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +575 other locations